Subtype
Vaginal Neoplasm
CI-CAN-00004230Explore in graph →
Non-malignant33 active trials1 evidence items
Loading cancer entity…
Subtype
CI-CAN-00004230Explore in graph →
Clinical trials
148 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04895020 | Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years | unknown | Phase 3 | 1,200 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 17, 2024 | clinicaltrials |
| NCT05787535 | HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor | unknown | Phase 1 | 17 | HRYZ Biotech Co.INDUSTRY | 1 | Feb 2, 2024 | clinicaltrials |
| NCT05931354 |
| Longitudinal HPV Pap in CIN and VAIN(LHPCV) |
| unknown |
| — |
| 600 |
| Chang Gung Memorial HospitalOTHER |
| 1 |
| Jul 5, 2023 |
| clinicaltrials |
| NCT05925361 | Peritoneum Vaginoplasty; Implementation According to IDEAL Framework(PeriVaS) | unknown | N/A | 13 | Amsterdam UMC, location VUmcOTHER | 1 | Jun 29, 2023 | clinicaltrials |
| NCT04704908 | Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls (54m) | unknown | — | 979 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT04969445 | The Durability of Protection Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | unknown | — | 647 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05045755 | The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Female | unknown | — | 1,339 | Jun ZhangOTHER | 1 | Jan 26, 2023 | clinicaltrials |
| NCT05561413 | Gynaecology Exercise and Mindfulness Study(GEMS) | unknown | N/A | 40 | University of UlsterOTHER | 1 | Oct 3, 2022 | clinicaltrials |
| NCT05536843 | Clinical, Translational and Biomarker-Based Female Genital HPV Induced Dysplasia and Cancer Screening Study Using Cf-HPV-DNA Blood Tests(TTMV HPV DNA) | unknown | — | 500 | University of Mississippi Medical CenterOTHER | 0 | Sep 13, 2022 | clinicaltrials |
| NCT03611517 | Sexual Rehabilitation Programme After Radiotherapy for Gynaecological Cancer(SPARC) | unknown | N/A | 220 | Leiden University Medical CenterOTHER | 1 | Feb 24, 2020 | clinicaltrials |
| NCT00800644 | Pelvic Fractures and Radiation Therapy for Cervical Cancer | unknown | — | 239 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 13, 2020 | clinicaltrials |
| NCT02458001 | Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer(SAFFRON) | unknown | N/A | 100 | University College, LondonOTHER | 0 | May 29, 2015 | clinicaltrials |
| NCT00601406 | Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer | unknown | N/A | 2,200 | The Christie NHS Foundation TrustOTHER | 1 | Aug 26, 2013 | clinicaltrials |
| NCT01087268 | Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer | unknown | Phase 3 | 75 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jul 15, 2011 | clinicaltrials |
| NCT00905658 | Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastatic Gynecological Cancer | unknown | Phase 2 | 120 | Centre Oscar LambretOTHER | 1 | Jul 29, 2009 | clinicaltrials |
| NCT00391664 | Questionnaire Study for Gynecological Cancer Survivors | unknown | — | 1,000 | U.S. Army Medical Research and Development CommandFED | 1 | Jun 30, 2008 | clinicaltrials |
Data updated 22 days agoSource updated Apr 17, 2024source: clinicaltrials